Used in the treatment of bacterial infections such as pharyngitis, tonsillitis, and community-acquired pneumonia, this compound is effective against susceptible strains of Streptococcus pyogenes and Haemophilus influenzae. It is also prescribed for skin and soft tissue infections caused by Staphylococcus aureus and Streptococcus pyogenes. Due to its oral bioavailability, it is commonly formulated in tablets and suspensions for outpatient use. Its activity stems from inhibiting bacterial cell wall synthesis, leading to cell lysis and death.